Citation Impact
Citing Papers
The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
2008 Standout
Systematic discovery of multicomponent therapeutics
2003
Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
2021 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Inhibition of Vascular Endothelial Growth Factor (VEGF) Signaling in Cancer Causes Loss of Endothelial Fenestrations, Regression of Tumor Vessels, and Appearance of Basement Membrane Ghosts
2004
Which is the best surgery for budd-chiari syndrome: Venous decompression or liver transplantation? a single-center experience with 50 patients
1995
EGFR Antagonists in Cancer Treatment
2008 Standout
Pericytes are required for blood–brain barrier integrity during embryogenesis
2010 StandoutNature
A phase I surrogate endpoint study of SU6668 in patients with solid tumors
2004
The Concept of Synthetic Lethality in the Context of Anticancer Therapy
2005 StandoutNobel
Delayed graft function in kidney transplantation
2004 Standout
Outcome of Budd-Chiari syndrome: A multivariate analysis of factors related to survival including surgical portosystemic shunting
1999
RETROVIRAL DELIVERY OF VIRAL INTERLEUKIN-10 INTO MYELOID DENDRITIC CELLS MARKEDLY INHIBITS THEIR ALLOSTIMULATORY ACTIVITY AND PROMOTES THE INDUCTION OF T-CELL HYPORESPONSIVENESS1,2
1998
Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome
2006
Engineering Novel Cell Surface Receptors for Virus-mediated Gene Transfer
1999 StandoutNobel
Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome
2004
Forces in Tissue Morphogenesis and Patterning
2013 Standout
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
Hypoxia‐inducible factor 1α/vascular endothelial growth factor axis in astrocytomas. Associations with microvessel morphometry, proliferation and prognosis
2004
Hepatitis B and Hepatitis C Viruses in Liver Transplantation
2004
Liver transplantation for Budd–Chiari syndrome: A European study on 248 patients from 51 centres
2005
Impact of donor infections on outcome of orthotopic liver transplantation
2003
Treatment of Budd-Chiari syndrome with portosystemic shunt or liver transplantation
1996
TIPS for acute and chronic Budd–Chiari syndrome: a single-centre experience
2003
Lung Cancer
2008 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
The prognostic value of histology in the assessment of patients with Budd–Chiari syndrome
2001
Twenty years of liver transplantation for Budd-Chiari syndrome: A national registry analysis
2007
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
Pericytes: gatekeepers in tumour cell metastasis?
2007
Allograft transduction of IL-10 prolongs survival following orthotopic liver transplantation
1999
A 10-Year Experience of Liver Transplantation for Hepatitis C: Analysis of Factors Determining Outcome in Over 500 Patients
2001
Vascular disorders of the liver # †
2008 Standout
High incidence of recurrence and hematologic events following liver transplantation for Budd–Chiari syndrome
2005
Adenoviral vectors given intravenously to immunocompromised mice yield stable transduction of the colonic epithelium
1997 StandoutNobel
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
The antiepidermal growth factor receptor monoclonal antibody cetuximab/C225 reduces hypoxia-inducible factor-1 alpha, leading to transcriptional inhibition of vascular endothelial growth factor expression
2005
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
Interleukin-17 and Type 17 Helper T Cells
2009 Standout
Hepatitis C and Liver Transplantation: Enhancing Outcomes and Should Patients Be Retransplanted
2008
Tumor necrosis factor inhibitor ameliorates murine intestinal graft-versus-host disease
1999 StandoutNobel
Primary Budd-Chiari syndrome: Outcome of endovascular management for suprahepatic venous obstruction
2006
Angiogenesis in life, disease and medicine
2005 StandoutNature
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Adenovirus-Mediated Gene Transfer of Viral Interleukin-10 Inhibits the Immune Response to Both Alloantigen and Adenoviral Antigen
1997
Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content
2007
Malignant Gliomas in Adults
2008 Standout
Mesenchymal Stem Cells Over-expressing Hepatocyte Growth Factor Improve Small-for-size Liver Grafts Regeneration
2007
Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors
2003
Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells
2006 StandoutNobel
Intracoronary adenovirus-mediated transfer of immunosuppressive cytokine genes prolongs allograft survival
1997
Cancer immunotherapy comes of age
2011 StandoutNature
Activation-Induced Cytidine Deaminase Expression in CD4+ T Cells is Associated with a Unique IL-10-Producing Subset that Increases with Age
2011 StandoutNobel
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11
2003
CASK Functions as a Mg2+-Independent Neurexin Kinase
2008 StandoutNobel
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
DECREASED ALLOREACTIVITY TO HUMAN ISLETS SECRETING RECOMBINANT VIRAL INTERLEUKIN 101
1996
Pericytes and ocular diseases
2007
Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection
2011 StandoutNobel
PDGFRβ+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival
2005
The association between hepatitis C infection and survival after orthotopic liver transplantation
2002
Infection in Solid-Organ Transplant Recipients
2007 Standout
Effect of VEGF receptor-2 antibody on vascular function and oxygenation in spontaneous and transplanted tumors
2004
Pericytes regulate the blood–brain barrier
2010 StandoutNature
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Emerging roles of pseudokinases
2006
Cell cycle kinases as therapeutic targets for cancer
2009
The role of pericytes in blood-vessel formation and maintenance
2005
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Angiogenesis as a therapeutic target
2005 StandoutNature
Tumor Angiogenesis
2008 Standout
Alternative activation of macrophages
2003 Standout
Antibacterial drug discovery in the resistance era
2016 StandoutNature
Budd-Chiari Syndrome: Current Management Options
2001
Pericytes and vessel maturation during tumor angiogenesis and metastasis
2010
Pretransplant MELD Score As a Predictor of Outcome After Liver Transplantation for Chronic Hepatitis C
2003
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Hematopoietic Stem Cell Development Is Dependent on Blood Flow
2009
Costimulation via Glucocorticoid-Induced TNF Receptor in Both Conventional and CD25+ Regulatory CD4+ T Cells
2004 StandoutNobel
The bone marrow constitutes a reservoir of pericyte progenitors
2006
Development of Biologic Markers of Response and Assessment of Antiangiogenic Activity in a Clinical Trial of Human Recombinant Endostatin
2002
Phase II Study of Imatinib Mesylate Plus Hydroxyurea in Adults With Recurrent Glioblastoma Multiforme
2005
Transfer Of The Interleukin-1 Receptor Antagonist Gene Into Rat Liver Abrogates Hepatic Ischemia-Reperfusion Injury
2002
Activation and Differentiation of Autoreactive B-1 Cells by Interleukin 10 Induce Autoimmune Hemolytic Anemia in Fas-deficient Antierythrocyte Immunoglobulin Transgenic Mice
2002 StandoutNobel
Characterization of an Adenovirus Vector Containing a Heterologous Peptide Epitope in the HI Loop of the Fiber Knob
1998
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Safety, Pharmacokinetic, and Antitumor Activity of SU11248, a Novel Oral Multitarget Tyrosine Kinase Inhibitor, in Patients With Cancer
2005
Cancer Genome Landscapes
2013 StandoutScience
Endothelial Hypoxia-Inducible Factor-2α Is Required for the Maintenance of Airway Microvasculature
2019 StandoutNobel
A Vascular Endothelial Growth Factor Receptor-2 Inhibitor Enhances Antitumor Immunity through an Immune-Based Mechanism
2007
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Pathways Mediating Resistance to Vascular Endothelial Growth Factor–Targeted Therapy
2008
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Microarray analysis of blood microvessels from PDGF‐B and PDGF‐Rβ mutant mice identifies novel markers for brain pericytes
2006
Second-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
2007
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
A Multitargeted, Metronomic, and Maximum-Tolerated Dose “Chemo-Switch” Regimen is Antiangiogenic, Producing Objective Responses and Survival Benefit in a Mouse Model of Cancer
2004
Works of Kenneth E. Drazan being referenced
ADENOVIRUS-MEDIATED GENE TRANSFER IN THE TRANSPLANT SETTING
1995
Neuronal Nitric Oxide Synthase Contributes to the Regulation of Hematopoiesis
2008
Transduction of Hepatic Allografts Achieves Local Levels of Viral IL-10 Which Suppress Alloreactivity in Vitro
1995
Orthotopic Liver Transplantation for Hepatitis C
1999
Hepatic Function Is Preserved Following Liver-Directed, Adenovirus-Mediated Gene Transfer
1995
A SIMPLE MODEL TO ESTIMATE SURVIVAL AFTER RETRANSPLANTATION OF THE LIVER1
1999
REGENERATION-INDUCED ACCELERATED REJECTION IN REDUCED-SIZE LIVER GRAFTS
1994
Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors
2001
ADENOVIRUS-MEDIATED GENE TRANSFER IN THE TRANSPLANT SETTING
1996
Efficient Gene Transfer To Pancreatic Islets Mediated By Adenoviral Vectors
1995
Adenovirus-mediated gene transfer in the transplant setting. II. Successful expression of transferred cDNA in syngeneic liver grafts.
1994
Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms.
2001
Portosystemic shunt versus orthotopic liver transplantation for the Budd-Chiari syndrome.
1992
Efficient Gene Transfer To Pancreatic Islets Mediated By Adenoviral Vectors
1995
Effects of an antibody to vascular endothelial growth factor receptor-2 on survival, tumor vascularity, and apoptosis in a murine model of colon carcinomatosis
2001
ADENOVIRUS-MEDIATED GENE TRANSFER IN THE TRANSPLANT SETTING
1994